English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment Journal article
Yang, Zhenyun, Wang, Xin, Fu, Yizhen, Wu, Weijie, Hu, Zili, Lin, Qingyang, Peng, Wei, Pan, Yangxun, Wang, Juncheng, Chen, Jinbin, Hu, Dandan, Zhou, Zhongguo, Xu, Li, Zhang, Yaojun, Hou, Jiajie, Chen, Minshan. YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment[J]. Molecular Cancer, 2024, 23(1), 186.
Authors:  Yang, Zhenyun;  Wang, Xin;  Fu, Yizhen;  Wu, Weijie;  Hu, Zili; et al.
Favorite | TC[WOS]:3 TC[Scopus]:2  IF:27.7/31.3 | Submit date：2024/10/10
Exploring the anti-hepatocellular carcinoma effects of Xianglian Pill: Integrating network pharmacology and RNA sequencing via in silico and in vitro studies Journal article
Huang, Jihan, Shi, Ruipeng, Chen, Feiyu, Tan, Hor Yue, Zheng, Jinbin, Wang, Ning, Li, Ran, Wang, Yulin, Yang, Tao, Feng, Yibin, Zhong, Zhangfeng. Exploring the anti-hepatocellular carcinoma effects of Xianglian Pill: Integrating network pharmacology and RNA sequencing via in silico and in vitro studies[J]. Phytomedicine, 2024, 133, 155905.
Authors:  Huang, Jihan;  Shi, Ruipeng;  Chen, Feiyu;  Tan, Hor Yue;  Zheng, Jinbin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:6.7/6.2 | Submit date：2024/09/03
Xianglian Pill  Hepatocellular Carcinoma  Network Pharmacology  Rna Sequencing  Big Data